Cargando…
Application of Immuno-PET in Antibody–Drug Conjugate Development
Targeted therapies hold great promise for cancer treatment and may exhibit even greater efficacy when combined with patient selection tools. The clinical impact of identifying likely responders includes reducing the number of unnecessary and ineffective therapies as well as more accurately determini...
Autores principales: | Carmon, Kendra S., Azhdarinia, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207972/ https://www.ncbi.nlm.nih.gov/pubmed/30370812 http://dx.doi.org/10.1177/1536012118801223 |
Ejemplares similares
-
ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1
por: Williams, Simon-Peter, et al.
Publicado: (2016) -
Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
por: Dewulf, Jonatan, et al.
Publicado: (2020) -
ImmunoPET: Antibody-Based PET Imaging in Solid Tumors
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2022) -
PREPARATION OF ANTIBODY-FERRITIN CONJUGATES FOR IMMUNO-ELECTRON MICROSCOPY
por: Ram, J. Sri, et al.
Publicado: (1963) -
Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications
por: Fu, Ruisi, et al.
Publicado: (2018)